What is the appropriate evaluation and management for a 50-year-old male with iron overload affecting the liver and spine?

Iron Deposits in Liver and Spine: Evaluation and Management

For a 50-year-old male with iron deposits in the liver and spine, you should immediately obtain MRI quantification of hepatic iron concentration using R2-based relaxometry, measure serum ferritin and transferrin saturation, and perform HFE genetic testing for C282Y homozygosity to determine if this is hereditary hemochromatosis requiring urgent phlebotomy.* 1, 2

Initial Diagnostic Workup

The presence of iron in both liver and spine indicates systemic iron overload requiring immediate quantification and etiologic diagnosis:

Laboratory Assessment

• Serum ferritin and transferrin saturation - These are your initial screening tests, though ferritin is non-specific and elevated in inflammation 1, 3
• HFE genetic testing - Specifically test for C282Y homozygosity, which accounts for >95% of hereditary hemochromatosis cases 4
• Exclude secondary causes - Check for chronic liver disease, inflammatory conditions, excessive alcohol use, and metabolic syndrome features (measure waist circumference) 4

Imaging Quantification

MRI with R2-based relaxometry is the gold standard for quantifying liver iron concentration (LIC) and assessing extrahepatic organ involvement* 1, 2. This technique:

• Provides accurate, reproducible LIC measurement in mg/g of tissue
• Assesses iron distribution in liver, spleen, pancreas, heart, and spine
• Is superior to serum markers alone, which are insufficient to confirm iron overload 1
• Should be performed at 1.5T or 3T with commercially available confounder-corrected software 2

The 2022 EASL guidelines specifically recommend MRI for patients with unclear hyperferritinemia, biochemical iron overload, or positive liver iron staining 1.

Risk Stratification

Cardiac Assessment

Obtain cardiac MRI if there are any signs of heart disease, as cardiac iron deposition causes myocardial dysfunction and fatal arrhythmias 1, 5. Cardiac T2* values do not correlate with liver iron or serum ferritin, requiring separate evaluation 6.

Hepatic Fibrosis Screening

If serum ferritin exceeds 1000 μg/L, perform liver elastography to identify advanced hepatic fibrosis, which significantly impacts prognosis and management 4.

Treatment Algorithm

For C282Y Homozygotes (Type 1 Hemochromatosis)

Initiate therapeutic phlebotomy immediately if:

• Serum ferritin ≥300 μg/L in men or ≥200 μg/L in women 7
• Regardless of symptoms 7

Phlebotomy protocol:

1. Induction phase: Remove 1 unit (450-500 mL) weekly until serum ferritin reaches 10-20 μg/L 7
2. Maintenance phase: Keep serum ferritin ≤50 μg/L with periodic phlebotomy 7

This approach prevents hepatic cirrhosis, hepatocellular carcinoma, diabetes, hypogonadism, arthropathy, and cardiomyopathy when started before severe iron overload develops 7.

For Non-C282Y Genotypes

If the patient is C282Y/H63D compound heterozygous or H63D homozygous, investigate additional environmental or genetic risk factors (alcohol, metabolic syndrome, other genetic variants) 1. Management includes:

• Phlebotomy for documented iron overload (14-30% of phlebotomy patients are compound heterozygotes) 1
• Address metabolic risk factors: weight loss, increased physical activity for fatty liver disease 1
• Reduce alcohol consumption if elevated, as this increases fibrosis and hepatocellular carcinoma risk 1

For Secondary Iron Overload

If iron overload is secondary to transfusion-dependent conditions or ineffective erythropoiesis:

• Initiate chelation when hepatic iron content exceeds 120 μmol/g 4
• Deferasirox is first-line oral chelation 4
• Deferiprone may be preferred despite neutropenia risk 4
• Deferoxamine (parenteral) for severe overload or emergencies 4

Monitoring Strategy

During Treatment

• Serum ferritin changes within 6 months of chelation therapy 6
• MRI T2 values* require longer follow-up periods to demonstrate change 6
• Monitor for phlebotomy complications and treatment tolerance

Long-term Surveillance

• Maintain serum ferritin ≤50 μg/L with maintenance phlebotomy 7
• Periodic MRI reassessment of organ iron burden
• Screen for complications: liver disease, diabetes, cardiac dysfunction, arthropathy

Critical Pitfalls to Avoid

Do not rely on serum ferritin alone - it is elevated in inflammation, infection, liver disease, and malignancy, making it non-specific for iron overload 1, 2. Always confirm with transferrin saturation and MRI quantification.

Do not assume cardiac iron correlates with liver iron - these organs accumulate iron independently and require separate MRI assessment 6. Cardiac involvement can be life-threatening and demands specific evaluation.

Do not perform phlebotomy in dysmetabolic iron overload syndrome without clear benefit - these patients often tolerate bloodletting poorly 4. Focus on metabolic risk factor modification instead.

Do not test for H63D variant routinely - the expert panel agrees this is unnecessary for hemochromatosis diagnosis 1. Only relevant if incidentally found during HFE genotyping.

Dietary Modifications

• Avoid medicinal iron and mineral supplements
• Avoid excess vitamin C (increases iron absorption)
• Avoid uncooked seafood (Vibrio infection risk in liver disease)
• Reduce alcohol consumption 7